The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
Altree TJ, Aishah A, Loffler KA, Grunstein RR, Eckert DJ.
Altree TJ, et al. Among authors: eckert dj.
J Clin Sleep Med. 2023 Jan 1;19(1):85-96. doi: 10.5664/jcsm.10256.
J Clin Sleep Med. 2023.
PMID: 36004739
Free PMC article.
Clinical Trial.
id=374614&isReview=true; Identifier: ACTRN12620000662965. CITATION: Altree TJ, Aishah A, Loffler KA, Grunstein RR, Eckert DJ. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, ran …
id=374614&isReview=true; Identifier: ACTRN12620000662965. CITATION: Altree TJ, Aishah A, Loffler KA, Grunstein RR, Eckert DJ …